HIV Citations List: April, 2016

Literature Citations

1. Triterpene Constituents of Euphorbia erythradenia Bioss. and Their anti-HIV Activity. Ayatollahi, A.M., S.M. Zarei, A. Memarnejadian, M. Ghanadian, M.H. Moghadam, and F. Kobarfard. Iranian Journal of Pharmaceutical Research, 2016. 15: p. 19-27. ISI[000372435700002].

[WOS]. HIV_04_2016.

2. A Broad Spectrum anti-HIV Inhibitor Significantly Disturbs V1/V2 Domain Rearrangements of HIV-1 gp120 and Inhibits Virus Entry. Berinyuy, E. and M.E. Soliman. Journal of Receptors and Signal Transduction Research, 2016. 36(2): p. 119-129. PMID[26446906].

[PubMed]. HIV_04_2016.

3. Dasatinib Inhibits HIV-1 Replication through the Interference of SAMHD1 Phosphorylation in CD4+ T Cells. Bermejo, M., M.R. Lopez-Huertas, J. Garcia-Perez, N. Climent, B. Descours, J. Ambrosioni, E. Mateos, S. Rodriguez-Mora, L. Rus-Bercial, M. Benkirane, J.M. Miro, M. Plana, J. Alcami, and M. Coiras. Biochemical Pharmacology, 2016. 106: p. 30-45. PMID[26851491].

[PubMed]. HIV_04_2016.

4. Design and Synthesis of Small Molecule-Sulfotyrosine Mimetics that Inhibit HIV-1 Entry. Dogo-Isonagie, C., S.L. Lee, K. Lohith, H. Liu, S.R. Mandadapu, S. Lusvarghi, R.D. O'Connor, and C.A. Bewley. Bioorganic & Medicinal Chemistry, 2016. 24(8): p. 1718-1728. PMID[26968647].

[PubMed]. HIV_04_2016.

5. Synthesis and Antiviral Evaluation of 1-[(2-Phenoxyethyl)oxymethyl] and 6-(3,5-Dimethoxybenzyl) Analogues of HIV Drugs Emivirine and TNK-651. El-Brollosy, N.R. and R. Loddo. Drug Research, 2016. 66(4): p. 181-188. PMID[26313923].

[PubMed]. HIV_04_2016.

6. Synthesis and in Vitro Screening of New Series of 2,6-Dipeptidyl-anthraquinones: Influence of Side Chain Length on HIV-1 Nucleocapsid Inhibitors. Frecentese, F., A. Sosic, I. Saccone, E. Gamba, K. Link, A. Miola, M. Cappellin, M.G. Cattelan, B. Severino, F. Fiorino, E. Magli, A. Corvino, E. Perissutti, D. Fabris, B. Gatto, G. Caliendo, and V. Santagada. Journal of Medicinal Chemistry, 2016. 59(5): p. 1914-1924. PMID[26797100].

[PubMed]. HIV_04_2016.

7. Testing anti-HIV Activity of Antiretroviral Agents in Vitro Using Flow Cytometry Analysis of CEM-GFP Cells Infected with Transfection-Derived HIV-1 NL4-3. Frezza, C., S. Grelli, M. Federico, F. Marino-Merlo, A. Mastino, and B. Macchi. Journal of Medical Virology, 2016. 88(6): p. 979-986. ISI[000373627000008].

[WOS]. HIV_04_2016.

8. Sulforaphane Inhibits HIV Infection of Macrophages Through Nrf2. Furuya, A.K., H.J. Sharifi, R.M. Jellinger, P. Cristofano, B. Shi, and C.M. de Noronha. Plos Pathogens, 2016. 12(4): p. e1005581. PMID[27093399]. PMCID[PMC4836681].

[PubMed]. HIV_04_2016.

9. 1,6-Bis[(Benzyloxy)methyl]uracil Derivatives-Novel Antivirals with Activity against HIV-1 and Influenza H1N1 Virus. Geisman, A.N., V.T. Valuev-Elliston, A.A. Ozerov, A.L. Khandazhinskaya, A.O. Chizhov, S.N. Kochetkov, C. Pannecouque, L. Naesens, K.L. Seley-Radtke, and M.S. Novikov. Bioorganic & Medicinal Chemistry, 2016. 24(11): p. 2476-2485. PMID[27112451].

[PubMed]. HIV_04_2016.

10. Litsea Species as Potential Antiviral Plant Sources. Guan, Y., D. Wang, G.T. Tan, N. Van Hung, N.M. Cuong, J.M. Pezzuto, H.H. Fong, D.D. Soejarto, and H. Zhang. The American Journal of Chinese Medicine, 2016. 44(2): p. 275-290. PMID[27080941].

[PubMed]. HIV_04_2016.

11. Polyanionic Macromolecular Prodrugs of Ribavirin: Antiviral Agents With a Broad Spectrum of Activity. Hinton, T.M., K. Zuwala, C. Deffrasnes, S. Todd, S.N. Shi, G.A. Marsh, M. Dearnley, B.M. Wohl, M. Tolstrup, and A.N. Zelikin. Advanced Healthcare Materials, 2016. 5(5): p. 534-540. PMID[26789641].

[PubMed]. HIV_04_2016.

12. Naturally Occurring Thiophenes: Isolation, Purification, Structural Elucidation, and Evaluation of Bioactivities. Ibrahim, S.R.M., H.M. Abdallah, A.M. El-Halawany, and G.A. Mohamed. Phytochemistry Reviews, 2016. 15(2): p. 197-220. ISI[000372950600002].

[WOS]. HIV_04_2016.

13. Exploring Isoxazole and Carboxamide Derivatives as Potential Non-Nucleoside Reverse Transcriptase Inhibitors. Kurup, S.S. and K.A. Joshi. Journal of Molecular Graphics and Modeling, 2016. 65: p. 113-128. PMID[26973048].

[PubMed]. HIV_04_2016.

14. A Minor Subset of Super Elongation Complexes Plays a Predominant Role in Reversing HIV-1 Latency. Li, Z.C., H.S. Lu, and Q. Zhou. Molecular and Cellular Biology, 2016. 36(7): p. 1194-1205. PMID[26830226]. PMCID[PMC4800791].

[PubMed]. HIV_04_2016.

15. Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor Agents: Optimization of Diarylanilines with High Potency against Wild-type and Rilpivirine-resistant E138K Mutant Virus. Liu, N., L. Wei, L. Huang, F. Yu, W. Zheng, B. Qin, D.Q. Zhu, S.L. Morris-Natschke, S. Jiang, C.H. Chen, K.H. Lee, and L. Xie. Journal of Medicinal Chemistry, 2016. 59(8): p. 3689-3704. PMID[27070547].

[PubMed]. HIV_04_2016.

16. The BET Inhibitor OTX015 Reactivates Latent HIV-1 Through P-TEFb. Lu, P., X. Qu, Y. Shen, Z. Jiang, P. Wang, H. Zeng, H. Ji, J. Deng, X. Yang, X. Li, H. Lu, and H. Zhu. Scientific Reports, 2016. 6: p. 24100. PMID[27067814]. PMCID[PMC4828723].

[PubMed]. HIV_04_2016.

17. Small-molecule CD4-mimics: Structure-based Optimization of HIV-1 Entry Inhibition. Melillo, B., S.Y. Liang, J. Park, A. Schon, J.R. Courter, J.M. LaLonde, D.J. Wendler, A.M. Princiotto, M.S. Seaman, E. Freire, J. Sodroski, N. Madani, W.A. Hendrickson, and A.B. Smith. ACS Medicinal Chemistry Letters, 2016. 7(3): p. 330-334. PMID[26985324]. PMCID[PMC4789667].

[PubMed]. HIV_04_2016.

18. Antiretroviral (HIV-1) Activity of Azulene Derivatives. Peet, J., A. Selyutina, and A. Bredihhin. Bioorganic & Medicinal Chemistry, 2016. 24(8): p. 1653-1657. PMID[26964674].

[PubMed]. HIV_04_2016.

19. The G-quadruplex-forming Aptamer AS1411 Potently Inhibits HIV-1 Attachment to the Host Cell. Perrone, R., E. Butovskaya, S. Lago, A. Garzino-Demo, C. Pannecouque, G. Palu, and S.N. Richter. International Journal of Antimicrobial Agents, 2016. 47(4): p. 311-316. PMID[27032748]. PMCID[PMC4840014].

[PubMed]. HIV_04_2016.

20. Anti-HIV-1 Integrase Effect of Compounds from Aglaia andamanica Leaves and Molecular Docking Study with Acute Toxicity Test in Mice. Puripattanavong, J., P. Tungcharoen, P. Chaniad, S. Pianwanit, and S. Tewtrakul. Pharmaceutical Biology, 2016. 54(4): p. 654-659. PMID[26427611].

[PubMed]. HIV_04_2016.

21. Evaluation and Synthesis of AZT Prodrugs with Optimized Chemical Stabilities: Experimental and Theoretical Analyses. Ribone, S.R., E.M. Schenfeld, M. Madrid, A.B. Pierini, and M.A. Quevedo. New Journal of Chemistry, 2016. 40(3): p. 2383-2392. ISI[000372425600061].

[WOS]. HIV_04_2016.

22. 2,6-Di(Arylamino)-3-fluoropyridine Derivatives as HIV Non-Nucleoside Reverse Transcriptase Inhibitors. Sergeyev, S., A.K. Yadav, P. Franck, J. Michiels, P. Lewi, J. Heeres, G. Vanham, K.K. Arien, C. Velde, H. De Winter, and B.U.W. Maes. Journal of Medicinal Chemistry, 2016. 59(5): p. 1854-1868. PMID[26785139].

[PubMed]. HIV_04_2016.

23. New 1(2H)-Phthalazinone Derivatives as Potent Nonpeptidic HIV-1 Protease Inhibitors: Molecular Docking Studies, Molecular Dynamics Simulation, Oral Bioavailability and ADME Prediction. Sroczynski, D., Z. Malinowski, A.K. Szczesniak, and W. Pakulska. Molecular Simulation, 2016. 42(8): p. 628-641. ISI[000372756700004].

[WOS]. HIV_04_2016.

24. Inhibitors of HIV-1 Maturation: Development of Structure-Activity Relationship for C-28 Amides Based on C-3 Benzoic acid-modified Triterpenoids. Swidorski, J.J., Z. Liu, S.Y. Sit, J. Chen, Y. Chen, N. Sin, B.L. Venables, D.D. Parker, B. Nowicka-Sans, B.J. Terry, T. Protack, S. Rahematpura, U. Hanumegowda, S. Jenkins, M. Krystal, I.B. Dicker, N.A. Meanwell, and A. Regueiro-Ren. Bioorganic & Medicinal Chemistry Letters, 2016. 26(8): p. 1925-1930. PMID[26988305].

[PubMed]. HIV_04_2016.

25. Ebselen, a Small-molecule Capsid Inhibitor of HIV-1 Replication. Thenin-Houssier, S., I.M. de Vera, L. Pedro-Rosa, A. Brady, A. Richard, B. Konnick, S. Opp, C. Buffone, J. Fuhrmann, S. Kota, B. Billack, M. Pietka-Ottlik, T. Tellinghuisen, H. Choe, T. Spicer, L. Scampavia, F. Diaz-Griffero, D.J. Kojetin, and S.T. Valente. Antimicrobial Agents and Chemotherapy, 2016. 60(4): p. 2195-2208. PMID[26810656]. PMCID[PMC4808204].

[PubMed]. HIV_04_2016.

26. HIV-1 Capsid Inhibitors as Antiretroviral Agents. Thenin-Houssier, S. and S.T. Valente. Current HIV Research, 2016. 14(3): p. 270-282. PMID[26957201]. PMCID[PMC4785820].

[PubMed]. HIV_04_2016.

27. Inhibition of HIV-1 Reverse Transcriptase Dimerization by Small Molecules. Tintori, C., A. Corona, F. Esposito, A. Brai, N. Grandi, E.R. Ceresola, M. Clementi, F. Canducci, E. Tramontano, and M. Botta. ChemBioChem, 2016. 17(8): p. 683-688. PMID[26946324].

[PubMed]. HIV_04_2016.

28. Antiviral Mechanism of Polyanionic Carbosilane Dendrimers against HIV-1. Vacas-Cordoba, E., M. Maly, F.J. De la Mata, R. Gomez, M. Pion, and M.A. Munoz-Fernandez. International Journal of Nanomedicine, 2016. 11: p. 1281-1294. PMID[27103798]. PMCID[PMC4827595].

[PubMed]. HIV_04_2016.

29. Design, Discovery, Modelling, Synthesis, and Biological Evaluation of Novel and Small, Low Toxicity S-triazine Derivatives as HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors. Viira, B., A. Selyutina, A.T. Garcia-Sosa, M. Karonen, J. Sinkkonen, A. Merits, and U. Maran. Bioorganic & Medicinal Chemistry, 2016. 24(11): p. 2519-2529. PMID[27108399].

[PubMed]. HIV_04_2016.

30. Design, Synthesis and anti-HIV-1 Evaluation of Hydrazide-based Peptidomimetics as Selective Gelatinase Inhibitors. Yang, L., P. Wang, J.F. Wu, L.M. Yang, R.R. Wang, W. Pang, Y.G. Li, Y.M. Shen, Y.T. Zheng, and X. Li. Bioorganic & Medicinal Chemistry, 2016. 24(9): p. 2125-2136. PMID[27039251].

[PubMed]. HIV_04_2016.

Patent Citations

31. Substituted Phenylpyrrolecarboxamides with Activity against HIV Infection. Debnath, A.K., F. Curreli, P.D. Kwong, and Y.D. Kwon. Patent. 2016. 2015-US51086 2016044808: 103pp.

[Patent]. HIV_04_2016.

32. Anti-HIV Compositions and Methods for Reactivating Latent Immunodeficiency Virus Using a SMYD2 Inhibitor. Ott, M. and D. Boehm. Patent. 2016. 2015-US55377 2016061131: 80pp.

[Patent]. HIV_04_2016.